(Q73317538)
Statements
CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients (English)
S Guérin
L Meyer
I Theodorou
F Boufassa
M Magierowska
C Goujard
C Rouzioux
P Debré
J F Delfraissy
SEROCO/HEMOCO Study Group